Raymond James Maintains Strong Buy Rating for Ventas: Here's What You Need To Know

Raymond James Maintains Strong Buy Rating for Ventas: Here's What You Need To Know

Raymond James has decided to maintain its Strong Buy rating of Ventas VTR and lower its price target from $60.00 to $55.00.

Shares of Ventas are trading up 0.91% over the last 24 hours, at $47.98 per share.

A move to $55.00 would account for a 14.62% increase from the current share price.

About Ventas

Ventas owns a diversified healthcare portfolio of over 1,200 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes over 40 properties in both Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 3% of NOI.

About Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-AAR-UPDATEAnalyst Ratings